Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 32.59% vs 32.48% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 3.17% vs 37.69% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 207.53% vs 21.67% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 62.02% vs -28.34% in Mar 2025
Compare Profit and Loss Results of Astrazeneca Phar
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,275.00
752.00
1,523.00
202.53%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,275.00
752.00
1,523.00
202.53%
Expenditure (Ex Depriciation)
Stock Adjustments
-488.00
24.00
-512.00
-2,133.33%
Raw Materials Consumed
1,868.00
213.00
1,655.00
777.00%
Power & Fuel Cost
2.00
14.00
-12.00
-85.71%
Employee Cost
264.00
52.00
212.00
407.69%
Operating Expenses
20.00
24.00
-4.00
-16.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
124.00
20.00
104.00
520.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
31.00
16.00
15.00
93.75%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,013.00
420.00
1,593.00
379.29%
Operating Profit (PBDIT) excl Other Income
262.00
331.00
-69.00
-20.85%
Other Income
28.00
134.00
-106.00
-79.10%
Operating Profit (PBDIT)
290.00
466.00
-176.00
-37.77%
Interest
4.00
0.00
4.00
0%
Profit before Depriciation and Tax
286.00
466.00
-180.00
-38.63%
Depreciation
28.00
24.00
4.00
16.67%
Profit Before Taxation & Exceptional Items
257.00
441.00
-184.00
-41.72%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
252.00
441.00
-189.00
-42.86%
Provision for Tax
64.00
102.00
-38.00
-37.25%
Profit After Tax
187.00
339.00
-152.00
-44.84%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
632.00
1,333.00
-701.00
-52.59%
Profit Available for appropriations
820.00
1,672.00
-852.00
-50.96%
Appropriations
820.00
1,672.00
-852.00
-50.96%
Equity Dividend (%)
1800%
300%
1,500.00
Earnings Per Share
75.01
44.67
30.34
67.92%
Profit And Loss - Net Sales
Net Sales 2,275.58 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 32.59% vs 32.48% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 262.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 3.17% vs 37.69% in Mar 2025
Profit And Loss - Interest
Interest 4.49 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 207.53% vs 21.67% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 187.52 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 62.02% vs -28.34% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
